Rate of Agreement for Manual and Automated Techniques for Determination of New T2 Lesions in Children with Multiple Sclerosis and Acute Demyelination (P2.242)

CONCLUSIONS: Agreement is high between manual and automated methods for new T2 lesion determination. Overall, the automated method is more sensitive than the manual readers and identifies a higher number of lesions.Study Supported by: Canadian Multiple Sclerosis Scientific Research FoundationDisclosure: Dr. Verhey has received research support from the Canadian Institutes of Health, and the Multiple Sclerosis Society of Canada. Dr. Elliott has nothing to disclose. Dr. Branson has nothing to disclose. Dr. Philpott has nothing to disclose. Dr. Shroff has nothing to disclose. Dr. Arbel has nothing to disclose. Dr. Banwell has received personal compensation in an editorial capacity for Multiple Sclerosis and Related Disorders. Dr. Banwell's institution has received research support from the Multiple Sclerosis Society of Canada, the Canadian Multiple Sclerosis Scientific Research Foundation, and Canadian Institute of Health Research. Dr. Arnold has received personal compensation for activities with Acorda Therapeutics, Bayer Pharmaceuticals Corporation, Biogen Idec, Coronado Biosciences, EMD Serono, Genentech Inc., Genzyme Corporation, GlaxoSmithKline Inc., MedImmune, NeuroRx Research. Dr. Arnold has received research support from Bayer Pharmaceuticals Corporation.

Source: Neurology - April 9, 2014 Category: Neurology Authors: Verhey, L., Elliott, C., Branson, H., Philpott, C., Shroff, M., Arbel, T., Banwell, B., Arnold, D. Tags: Pediatric Multiple Sclerosis and Other Demyelinating Diseases Source Type: research